Joel B. Nelson

University of Pittsburgh — United States

Medicine · Health Sciences

59h-index21.6kcitations492works0.52yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Prostate Cancer Treatment and Research(143), Prostate Cancer Diagnosis and Treatment(78), Hormonal and reproductive studies(38), Urological Disorders and Treatments(38), Urologic and reproductive health conditions(34)

Publications486 total

Benign prostatic hyperplasia nodules in patients treated with celecoxib and/or finasteride have reduced levels of NADH dehydrogenase [ubiquinone] iron‐sulfur protein 3, a mitochondrial protein essential for efficient function of the electron transport chain
The Prostate·2024· 1 citedOpen Access
PD03-06 MITOCHONDRIAL COMPLEX I PROTEIN NDUFS3 IS DECREASED IN BENIGN PROSTATIC HYPERPLASIA PATIENTS TREATED WITH CELECOXIB AND/OR FINASTERIDE
The Journal of Urology·2024
High-throughput ML-guided design of diverse single-domain antibodies against SARS-CoV-2
2023· 8 citedOpen Access
Supplemental Figure S3 from Hsp70 Binds to the Androgen Receptor N-terminal Domain and Modulates the Receptor Function in Prostate Cancer Cells
2023Open Access
Data from (+)-JJ-74–138 is a Novel Noncompetitive Androgen Receptor Antagonist
2023Open Access
Supplementary Data from (+)-JJ-74–138 is a Novel Noncompetitive Androgen Receptor Antagonist
2023Open Access
Supplementary Tables from A Novel Small Molecule Targets Androgen Receptor and Its Splice Variants in Castration-Resistant Prostate Cancer
2023Open Access
Data from Hsp70 Binds to the Androgen Receptor N-terminal Domain and Modulates the Receptor Function in Prostate Cancer Cells
2023Open Access
Data from Molecular Characterization of Neuroendocrine Prostate Cancer and Identification of New Drug Targets
2023Open Access
Supplementary Figures 1-15, Supplementary Tables 1-2, Supplementary Methods from Molecular Characterization of Neuroendocrine Prostate Cancer and Identification of New Drug Targets
2023Open Access
Supplementary Figure from (+)-JJ-74–138 is a Novel Noncompetitive Androgen Receptor Antagonist
2023Open Access
Supplementary Table 3 from Molecular Characterization of Neuroendocrine Prostate Cancer and Identification of New Drug Targets
2023Open Access
Supplementary Figures from A Novel Small Molecule Targets Androgen Receptor and Its Splice Variants in Castration-Resistant Prostate Cancer
2023Open Access
Supplemental Table S1 from Hsp70 Binds to the Androgen Receptor N-terminal Domain and Modulates the Receptor Function in Prostate Cancer Cells
2023Open Access
Data from A Novel Small Molecule Targets Androgen Receptor and Its Splice Variants in Castration-Resistant Prostate Cancer
2023Open Access
Supplementary Figures from A Novel Small Molecule Targets Androgen Receptor and Its Splice Variants in Castration-Resistant Prostate Cancer
2023Open Access
Supplemental Table S1 from Hsp70 Binds to the Androgen Receptor N-terminal Domain and Modulates the Receptor Function in Prostate Cancer Cells
2023Open Access
Supplementary Tables from A Novel Small Molecule Targets Androgen Receptor and Its Splice Variants in Castration-Resistant Prostate Cancer
2023Open Access
Data from (+)-JJ-74–138 is a Novel Noncompetitive Androgen Receptor Antagonist
2023Open Access
Data from Hsp70 Binds to the Androgen Receptor N-terminal Domain and Modulates the Receptor Function in Prostate Cancer Cells
2023Open Access
page 1 of 25Next →

Frequent Co-authors

Michael A. Carducci(7), Yan Yu(6), Jianhua Luo(6), George K. Michalopoulos(5), Susan L. Greenspan(5), George C. Tseng(5), Rajiv Dhir(4), Claude C. Schulman(4), Martin Gleave(3), Mark A. Rubin(3), Jeffrey A. Cadeddu(3), Stephen J. Freedland(3), Bao‐Guo Ren(3), Donald L. Trump(3), Neil M. Resnick(3), Fred Saad(3), Darryl J. Sleep(3), Karim Fizazi(3), Beth R. Pflug(3), Shivendra V. Singh(3)